Eastern Cooperative Oncology Group

This study tests a drug called daratumumab for people with T-cell acute lymphoblastic leukemia (T-ALL) who still have tiny amounts of cancer left after chemotherapy. The goal is to see if the drug can wipe out these leftover cells and lead to a complete remission. About 20 partic…

This study compares two approaches for adults with peripheral T-cell lymphoma who are in complete remission after initial chemotherapy: either a high-dose chemotherapy followed by a transplant of their own stem cells, or simply watching and waiting. The goal is to see if the tran…

This study looks at whether giving young adults (ages 18-39) with cancer the option to choose how they report their symptoms and well-being leads to better data. About 400 participants will be randomly assigned to either a fixed set of questions or a choice of questions. The goal…

This study looks at whether adding patient navigators and easy-to-understand educational materials can increase the number of Black and Latino cancer patients who are referred to and enroll in cancer clinical trials. About 500 patients from community oncology clinics will take pa…